Outcome
This pilot study showed that hyperbaric oxygen treatment (HBOT) significantly improved cognitive function in long-term brain tumor survivors who experienced severe cognitive deficits after neurosurgery and radiotherapy. Patients demonstrated a notable increase in the amplitude of the late event-related component P3b linked to object interpretation and improvements in memory performance as measured by the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE).
Introduction
A recent pilot study has highlighted the potential benefits of hyperbaric oxygen treatment (HBOT) for long-term brain tumor survivors suffering from severe cognitive deficits following neurosurgery and radiosurgery. The study investigated the neurophysiologic effects of HBOT on a group of ten patients examining various neuropsychological factors before and after treatment. Results demonstrated a significant improvement in the amplitude of the late event-related component P3b which is associated with object interpretation. Additionally memory performance showed enhancement according to the IQCODE questionnaire. Despite no changes in other EEG components latencies or reaction times the combined outcomes from multiple tests indicated notable cognitive improvements. Led by Nico A M Schellart and his team this preliminary report suggests HBOT’s promising role in enhancing brain function in this patient group.
Results
The study investigated the effects of hyperbaric oxygen treatment (HBOT) on cognitive performance in long-term brain tumor survivors who had previously undergone neurosurgery or radiotherapy. Ten patients were evaluated before HBOT and at intervals of 6 weeks and 4 months post-treatment using various neuropsychological tests and quantitative electroencephalography (EEG). The tests included the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for memory performance the number connection test (NCT) and the continuous reaction time test (CRTT).
Results indicated a significant improvement in the amplitude of the late event-related component (LERC) P3b which is crucial for object interpretation (P = .02). However other LERCs such as N200 and P3a as well as a positive occipital visual component showed no change in amplitude. Latencies and reaction times also did not change post-HBOT though P3a and P3b latencies were longer in survivors compared to healthy individuals. The IQCODE reported an improvement in memory performance. When combining the results from the NCT CRTT IQCODE and P3b amplitudes HBOT was associated with substantial cognitive improvements (P < .006).
In conclusion the study tentatively suggests that HBOT can enhance neurophysiologic performance in long-term brain tumor survivors specifically improving memory and cognitive processing as measured by EEG and cognitive assessments.
Conclusion
In conclusion this pilot study provides compelling evidence that hyperbaric oxygen treatment (HBOT) can significantly improve neurophysiologic performance in long-term brain tumor survivors who suffer from severe cognitive deficits following neurosurgery and radiotherapy. Specifically the study demonstrated a notable enhancement in the amplitude of the late event-related component (LERC) P3b which plays a critical role in object interpretation. Despite no significant changes in other EEG components latencies or reaction times the improvement in P3b amplitude along with positive results from the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) suggests an overall cognitive benefit from HBOT. These findings are promising indicating that HBOT could be a valuable therapeutic option for cognitive rehabilitation in post-treatment brain tumor patients. However further extensive studies are required to confirm these results and to better understand the mechanisms underlying the observed improvements. The study underscores the potential for HBOT to contribute to enhanced brain health and cognitive function in affected individuals marking an important step forward in neurorehabilitation research.